Emily M. Leproust
Tracked across 1 events · 6 articles · First seen Jun 12, 2026 · Last active Jun 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: As CEO and co-founder of Altor BioScience, Emily M. Leproust highlighted the flexibility and ease of adoption that advanced automation brings to their hybrid capture portfolio.
Jun 12, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Emily M. Leproust live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard